Robert Lisicki on Living Up to Zura Bio’s Heroic Namesake

In April 2024, Robert Lisicki began serving as CEO and director of the board for Zura Bio Limited. In this Pharmaceutical Executive interview, Lisicki discusses his time at the company, how his career shaped his leadership style, and what’s coming down the pipeline for Zura. The clinical-stage, multi-asset immunology company has treatments in Phase II studies in two areas that Lisicki describes as “high need.”

1:21 – Going beyond Lisicki’s LinkedIn profile and how he ended up on the path to leadership.

4:44 – Developing his leadership style and allowing the team to do its job.

6:20 – Learning how to get people to believe something that doesn’t seem achievable.

7:47 – Building a team by bringing in people who bring in results on a high level.

9:22 – What people should think when they hear the name Zura Bio for the first time.

10:38 – Zura’s mission statement tells a specific story.

12:01 – The outcomes that define success for Zura and awaiting good outcomes for Phase II studies.

14:27 – The importance for leaders to be authentically optimistic.

15:54 – The good side of politics is where people work together and find policy initiatives that help people.